AAAAAA

   
Results: 1-15 |
Results: 15

Authors: TSOUKAS CM RABOUD J BERNARD NF MONTANER JSG GILL MJ RACHLIS A FONG IW SCHLECH W DJURDJEV O FREEDMAN J THOMAS R LAFRENIERE R WAINBERG MA CASSOL S OSHAUGHNESSY M TODD J VOLVOVITZ F SMITH GE
Citation: Cm. Tsoukas et al., ACTIVE IMMUNIZATION OF PATIENTS WITH HIV-INFECTION - A STUDY OF THE EFFECT OF VAXSYN, A RECOMBINANT HIV ENVELOPE SUBUNIT VACCINE, ON PROGRESSION OF IMMUNODEFICIENCY, AIDS research and human retroviruses, 14(6), 1998, pp. 483-490

Authors: LEW J REICHELDERFER P FOWLER M BREMER J CARROL R CASSOL S CHERNOFF D COOMBS R CRONIN M DICKOVER R FISCUS S HERMAN S JACKSON B KORNEGAY J KOVACS A MCINTOSH K MEYER W MICHAEL N MOFENSON L MOYE J QUINN T ROBB M VAHEY M WEISER B YEGHIAZARIAN T
Citation: J. Lew et al., DETERMINATIONS OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - REASSESSMENT OF PARAMETERS AFFECTING ASSAY OUTCOME, Journal of clinical microbiology, 36(6), 1998, pp. 1471-1479

Authors: CASSOL S GILL MJ PILON R CORMIER M VOIGT RF WILLOUGHBY B FORBES J
Citation: S. Cassol et al., QUANTIFICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FROM DRIED PLASMA SPOTS COLLECTED ON FILTER-PAPER, Journal of clinical microbiology, 35(11), 1997, pp. 2795-2801

Authors: RABOUD JM MONTANER JSG THORNE A SINGER J SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C FANNING M CAMERON W LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SALOMON H SPIRA B CONWAY B AUCLAIR C CASSOL S OSHAUGHNESSY MV WAINBERG MA
Citation: Jm. Raboud et al., IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 46-55

Authors: CASSOL S WENIGER BG BABU PG SALMINEN MO ZHENG XW HTOON MT DELANEY A OSHAUGHNESSY M OU CY
Citation: S. Cassol et al., DETECTION OF HIV TYPE-1 ENV SUBTYPE-A, SUBTYPE-B, SUBTYPE-C, AND SUBTYPE-E IN ASIA USING DRIED BLOOD SPOTS - A NEW SURVEILLANCE TOOL FOR MOLECULAR EPIDEMIOLOGY, AIDS research and human retroviruses, 12(15), 1996, pp. 1435-1441

Authors: TSOUKAS CM RABOUD J BERNARD N DJURDJEV O CASSOL S CHERNOFF D FONG I FREEDMAN J GILL J GOLDBERG E LAFRENIERE R LEE S MONTANER J POON MC RACHLIS A SCHLECH W SMITH G SZABO J TODD J THOMAS R VOLVOVITZ F
Citation: Cm. Tsoukas et al., THERAPEUTIC VACCINATION - A RANDOMIZED CONTROLLED-STUDY OF THE EFFECTOF RGP160 ON PROGRESSION OF IMMUNE-DEFICIENCY AND VIRAL BURDEN, AIDS, 10, 1996, pp. 62-62

Authors: JANET R TSOUKAS C BERNARD N DJURDJEV O CASSOL S CHERNOFF D FONG I FREEDMAN J GILL J GOLDBERG E LAFRENIERE R LEE S MONTANER J POON MC RACHLIS A SCHLECH W SMITH G SZABO J TODD J THOMAS R VOLVOVITZ F
Citation: R. Janet et al., PLASMA VIREMIA IS MORE PREDICTIVE OF DISEASE PROGRESSION THAN CD4 COUNTS IN HIV-INFECTED INDIVIDUALS WITH CD4 COUNTS GREATER-THAN 500 IN A RANDOMIZED TRIAL OF IMMUNIZATION WITH RGP160, AIDS, 10, 1996, pp. 63-63

Authors: CHOU L BOUSTANY F NATHANSON D EPSTEIN J CASSOL S
Citation: L. Chou et al., G-]A HYPERMUTATION IN ENV LOOP V2 REGION OF HIV-1 GENE IN ORAL HAIRY LEUKOPLAKIA, Journal of dental research, 75, 1996, pp. 778-778

Authors: MERZOUKI A PATEL P CASSOL S ENNAJI M TAILOR P TURCOTTE FR OSHAUGHNESSY M ARELLA M
Citation: A. Merzouki et al., HIV-1 GP120 160 EXPRESSING CELLS UP-REGULATE HIV-1 LTR DIRECTED GENE-EXPRESSION IN A CELL-LINE TRANSFECTED WITH HIV-1 LTR - REPORTER GENE CONSTRUCTS/, Cellular and molecular biology, 41(3), 1995, pp. 445-452

Authors: MONTANER JSG SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C RABOUD J CAMERON B SALOMON H DUNKLE L SMALDONE L WAINBERG MA FANNING M LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SPIRA B CONWAY B CASSOL S OSHAUGNESSY M THORNE A SINGER J AUCLAIR C
Citation: Jsg. Montaner et al., DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/, Annals of internal medicine, 123(8), 1995, pp. 561-571

Authors: SHEN YN RUDNIK J CASSOL S DROUIN J CAMERON W IZAGUIRRE CA FILION LG
Citation: Yn. Shen et al., BLOOD MONOCYTES FROM MOST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS DO NOT CARRY PROVIRAL DNA, Clinical and diagnostic laboratory immunology, 1(5), 1994, pp. 531-537

Authors: MERZOUKI A MO T VELLANI N PATTULLO A ESTABLE M OSHAUGHNESSY M TSOUKAS C CASSOL S
Citation: A. Merzouki et al., ACCURATE AND DIFFERENTIAL QUANTITATION OF HIV-1 TAT, REV AND NEF MESSENGER-RNAS BY COMPETITIVE PCR, Journal of virological methods, 50(1-3), 1994, pp. 115-128

Authors: MERZOUKI A PATEL P CASSOL S OSHAUGHNESSY M GILL J ARELLA M
Citation: A. Merzouki et al., HIV-1 GP120 160 EXPRESSING TRANSFECTED CELL CLONES TO EVALUATE THE ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) DURING THE COURSE OF HIV-1 INFECTION/, Journal of virological methods, 48(1), 1994, pp. 9-21

Authors: CASSOL S BUTCHER A KINARD S SPADORO J SY T LAPOINTE N READ S GOMEZ P FAUVEL M MAJOR C OSHAUGHNESSY M
Citation: S. Cassol et al., RAPID SCREENING FOR EARLY DETECTION OF MOTHER-TO-CHILD TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of clinical microbiology, 32(11), 1994, pp. 2641-2645

Authors: COUTLEE F OLIVIER C CASSOL S VOYER H KESSOUSELBAZ A SAINTANTOINE P HE YL FAUVEL M
Citation: F. Coutlee et al., ABSENCE OF PROLONGED IMMUNOSILENT INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS IN INDIVIDUALS WITH HIGH-RISK BEHAVIORS, The American journal of medicine, 96(1), 1994, pp. 42-48
Risultati: 1-15 |